trial · primary record
RDX-002 + Olanzipine
Drug-induced Weight Gain
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2023-09-13 |
| Primary endpoint | Percent Difference Between the Two Treatment Arms for Postprandial Triglyceride Absolute Area Under the Curve (AUC) on Day 15 vs. Day : 0, 1, 2, 3, 4, 6, and 8 Hours Post Dose |
| Registry ID | NCT05857566 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:13.925Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05857566
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.